当前位置: 首页 > 期刊 > 《中国现代医生》 > 2017年第35期
编号:13207235
右美托咪定对无创通气AECOPD患者镇静的安全性及有效性研究(4)
http://www.100md.com 2017年12月15日 中国现代医生 2017年第35期
     [15]Constantin JM,Momon A,Mantz J,et al. Efficacy and safety of sedation with dexmedetomidine in critical care patients:A meta-analysis of randomized controlled trial[J].Anaesth Crit Care Pain Med,2015,35(1):7-15

    [16]Ebert TJ,Hall JE,Barney JA,et al. The effects of increasing plasma concentrations of dexmedetomidine in humans[J].Anesthesiology,2000,93(2):382-394.

    [17]Prielipp RC,Wall MH,Tobin JR,et al.Dexmedetomi-dineinduced sedation in volunteers decreases regional and global cerebral blood flow[J]. Anesth Analg,2012,95(4):1052-1059.

    [18]Shehabi Y,Ruettimann U,Adamson H,et al. Dexmedetomidine infusion for more than 24 hours in critically ill patients: Sedative and cardiovascular effects[J]. Intensive Care Med,2004,30(12):2188-2196.

    [19]Yu T,Li Q,Liu L,et al.Different effects of propofol and dexmedetomidine on preload dependency in endotoxemic shock with norepinephrine infusion[J].J Surg Res,2015, 198(1):185-191.

    [20]Kim KN,Lee HJ,Kim SY,et al.Combined use of dexmedetomidine and propofol in monitored anesthesia care:A randomized controlled study[J].BMC Anesthesiol,2017,17(1):34.

    [21]Jo YY,Kim HS,Lee KC,et al. Consort the effect of intraoperative dexmedetomidine on hemodynamic responses during emergence from nasotracheal intubation after oral surgery[J]. Medicine(Baltimore),2017,96(16):e6661.

    (收稿日期:2017-10-11), 百拇医药(俞国峰 应利君)
上一页1 2 3 4